Skip to main content
. 2018 Sep 14;19(9):2769. doi: 10.3390/ijms19092769

Figure 8.

Figure 8

Effect of BAPTA-AM on morphology of LLC-PK1 cells treated with telocinobufagin (TCB). Serum-starved LLC-PK1 cells were treated with 100 nM TCB and/or 5 μM BAPTA-AM in 2.5% FBS for 24 h and phase-contrast microscopy was performed for control (a), BAPTA (b), and TCB-treated cells without (c) or with BAPTA (d). Scale bar: 100 μm.